Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score.

Baocuo GongXuewen WangWangting Guo Hongyi YangYanhong ShiYaying Chen Simiao Gao Jialin Chen Lifang Liu Linbin LuXiong Chennull null

Published in: Journal of hepatocellular carcinoma (2023)

Our study confirms the prognostic value of the ALFP score in predicting the survival of HCC patients undergoing TACE. The score incorporates easily obtainable baseline parameters and provides a simple and practical tool for risk stratification and treatment decision-making in HCC patients.

Keyphrases

patients undergoing
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
replacement therapy